Hubei Biocause Pharmaceutical Co., Ltd. (000627.SZ) SHZ
1.58
+0.02(+1.28%)
Currency In CNY
- General
- Statistics
- Historical Data
- Profile
- Financials
Hubei Biocause Pharmaceutical Co., Ltd.
Sector
Financial Services
Industry
Insurance - Life
Employees
1765
First IPO Date
November 12, 1996
Key Executives
| Name | Title | Pay | Year Born |
| Dali Chen | Chief Financial Officer & Director | 0 | 1962 |
| Wenxia Zhou | Vice Chairman & GM | 0 | 1972 |
| Fei Long | Secretary of the Board & Non-Independent Director | 0 | 1979 |
Description
Hubei Biocause Pharmaceutical Co., Ltd. primarily provides life and motor insurance products in China. The company also engages in the pharmaceutical, chemical, and new energy fuel businesses. In addition, it is involved in the contract research and production of APIs, intermediates, and formulations, including tablets, granules, capsules, etc.; and provision of chemicals comprising dimethyl ether gas and a-chloropropionyl chloride. The company exports its products to the United States, the European Union, and internationally. Hubei Biocause Pharmaceutical Co., Ltd. is based in Jingmen, China.
